Drawing for Serial No. 79431751

USPTO serial 79431751

Serial No. 79431751

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
Examiner
SCHOEN,LINDSEY O
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).

Status 686: Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance.

Need help with Serial No. 79431751?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of systemic inflammatory and immunological conditions; pharmaceutical preparations for the treatment of oncological and hematological diseases; pharmaceutical preparations for the treatment of metabolic and endocrine disorders; pharmaceutical preparations for the treatment of neurological diseases; pharmaceutical preparations for the treatment of infectious diseasesACTIVE
042Scientific and technological services, namely, research and design in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software development in the fields of artificial intelligence, machine learning technologies, deep learning technologies, and reinforcement learning technologies, all for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; design and development of computer hardware and softwareACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 11, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 11, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 5, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 13, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jul 13, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 13, 2026XAECEXAMINER'S AMENDMENT ENTERED
Jul 13, 2026GNEAEXAMINERS AMENDMENT E-MAILED
Jul 13, 2026CNEAEXAMINERS AMENDMENT -WRITTEN
Jun 2, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jun 2, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 2, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 1, 2026ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Apr 1, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 1, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 1, 2026CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 1, 2026COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 5, 2026RFNTREFUSAL PROCESSED BY IB
Jan 22, 2026RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 22, 2026RFRRREFUSAL PROCESSED BY MPU
Dec 19, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 18, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 16, 2025DOCKASSIGNED TO EXAMINER
Sep 12, 2025MAFRAPPLICATION FILING RECEIPT MAILED
Sep 12, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 4, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance